Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rosemary M Olivero"'
Publikováno v:
Journal of the Pediatric Infectious Diseases Society.
Approximately 50% of human immunodeficiency virus (HIV)-infected adolescents fail to achieve complete viral suppression, largely due to nonadherence to their antiretroviral drug regimens. Numerous personal, financial, and societal barriers contribute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ee57b59c7d5ccd16036a053dd3cd9c
https://pubmed.ncbi.nlm.nih.gov/36525377
https://pubmed.ncbi.nlm.nih.gov/36525377
Autor:
Joshua Wolf, Mark J Abzug, Brenda I Anosike, Surabhi B Vora, Alpana Waghmare, Paul K Sue, Rosemary M Olivero, Carlos R Oliveira, Scott H James, Theodore H Morton, Gabriela M Maron, Jennifer L Young, Rachel C Orscheln, Hayden T Schwenk, Laura L Bio, Zachary I Willis, Elizabeth C Lloyd, Adam L Hersh, Charles W Huskins, Vijaya L Soma, Adam J Ratner, Molly Hayes, Kevin Downes, Kathleen Chiotos, Steven P Grapentine, Rachel L Wattier, Gabriella S Lamb, Philip Zachariah, Mari M Nakamura
Publikováno v:
Journal of the Pediatric Infectious Diseases Society, vol 11, iss 5
Background Starting in November 2020, the US Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing monoclonal antibody therapies, including bamlanivimab monotherapy (now revoked), baml
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5faa25d08ca067245f285e8472b21d4e
https://pubmed.ncbi.nlm.nih.gov/35107571
https://pubmed.ncbi.nlm.nih.gov/35107571